relative to affordability and safety of clinician administered drugs.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2023
Committee Review
Floor Vote
Governor
Introduced Jan 11, 2023
Last action Nov 16, 2023
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
13
Key actions
6
Committee
6
Nov 16, 2023
Lower · Passed
Committee Report: Refer for Interim Study 11/08/2023 (Vote 19-0; CC)
lower
Sep 6, 2023
Lower · Passed
==RESCHEDULED== Subcommittee Work Session: 09/20/2023 01:15 pm LOB 302-304 HC 36
lower
Aug 30, 2023
Lower · Passed
==CANCELLED== Subcommittee Work Session: 09/06/2023 01:15 pm LOB 302-304
lower
Mar 15, 2023
Lower · Passed
Retained in Committee
lower
Mar 8, 2023
Lower · Passed
Subcommittee Work Session: 03/15/2023 10:05 am LOB 302-304
lower
Feb 23, 2023
Lower · Passed
Subcommittee Work Session: 03/08/2023 10:00 am LOB 302-304
lower
Jan 11, 2023
Introduced
Introduced (in recess of) 01/05/2023 and referred to Commerce and Consumer Affairs HJ 3 P. 19
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Tim McGough
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 513
Scope: NH
Hi! I can help you understand HB 513. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline